{"id":28714,"date":"2026-06-12T10:34:44","date_gmt":"2026-06-12T17:34:44","guid":{"rendered":"https:\/\/magventure.com\/us\/?post_type=event&p=28714"},"modified":"2026-06-12T10:34:46","modified_gmt":"2026-06-12T17:34:46","slug":"clinical-insights-on-accelerated-tms-webinar","status":"publish","type":"event","link":"https:\/\/magventure.com\/us\/events\/clinical-insights-on-accelerated-tms-webinar\/","title":{"rendered":"Webinar – Clinical Insights on Accelerated TMS: From Evidence to Execution"},"content":{"rendered":"
\n
\n
\n
\n
\n \n \n Webinar\n<\/p>\n <\/div>\n

July 14 – July 14, 2026<\/p>\n <\/div>\n

Webinar – Clinical Insights on Accelerated TMS: From Evidence to Execution<\/h1>\n <\/div>\n
\n \"Webinar\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n
\n

Clinical Insights on Accelerated TMS: From Evidence to Execution\u00a0<\/strong><\/p>\n\n\n\n

Overview<\/strong><\/p>\n\n\n\n

Accelerated Transcranial Magnetic Stimulation (aTMS)<\/strong> protocols have emerged as a promising approach to reducing treatment duration while maintaining clinical effectiveness for patients with Major Depressive Disorder (MDD). As interest in accelerated treatment delivery continues to grow, clinicians are seeking practical guidance on protocol selection and implementation.<\/p>\n\n\n\n

Join us to hear from Dr. Andrew F. Leuchter<\/strong>, Distinguished Professor of Psychiatry and Director of the Neuromodulation Division at UCLA. An internationally recognized expert in mood disorders and neuromodulation, Dr. Leuchter directs UCLA’s Transcranial Magnetic Stimulation (TMS) Clinical and Research Service, one of the largest academic TMS programs in the United States.<\/p>\n\n\n\n

In this webinar, Dr. Leuchter will cover:<\/strong><\/p>\n\n\n\n